Article
- The EMBO Journal (2003) 22, 3887 - 3897
- doi:10.1093/emboj/cdg380
Subject Categories:
Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBP
and GATA factors
Barry Heavey2,3, Christoforos Charalambous1,3, Cesar Cobaleda1 and Meinrad Busslinger1
- Research Institute of Molecular Pathology, Vienna Biocenter, Dr. Bohr-Gasse 7, A-1030 Vienna, Austria
- Present address: Institute for Stem Cell Research, Kings Buildings, West Mains Road, Edinburgh EH9 3JQ, UK
- B.Heavey and C.Charalambous contributed equally to this work
Correspondence to:
Meinrad Busslinger, E-mail: busslinger@nt.imp.univie.ac.at
Received 19 August 2002; Accepted 10 June 2003; Revised 5 June 2003
Abstract
The developmental potential of hematopoietic progenitors is restricted early on to either the erythromyeloid or lymphoid lineages. The broad developmental potential of Pax5-/- pro-B cells is in apparent conflict with such a strict separation, although these progenitors realize the myeloid and erythroid potential with lower efficiency compared to the lymphoid cell fates. Here we demonstrate that ectopic expression of the transcription factors C/EBP
, GATA1, GATA2 and GATA3 strongly promoted in vitro macrophage differentiation and myeloid colony formation of Pax5-/- pro-B cells. GATA2 and GATA3 expression also resulted in efficient engraftment and myeloid development of Pax5-/- pro-B cells in vivo. The myeloid transdifferentiation of Pax5-/- pro-B cells was accompanied by the rapid activation of myeloid genes and concomitant repression of B-lymphoid genes by C/EBP
and GATA factors. These data identify the Pax5-/- pro-B cells as lymphoid progenitors with a latent myeloid potential that can be efficiently activated by myeloid transcription factors. The same regulators were unable to induce a myeloid lineage switch in Pax5+/+ pro-B cells, indicating that Pax5 dominates over myeloid transcription factors in B-lymphocytes.
Keywords:
- C,
- EBP
, - GATA factors,
- Pax5 mutantpro-B cells,
- myeloid lineage switch



